These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6085132)

  • 1. The systemic effect of cancers on human sera proton NMR relaxation times.
    Beall PT; Narayana PA; Amtey SR; Spiga L; Intra E; Ridella S; Mela GS
    Magn Reson Imaging; 1984; 2(2):83-7. PubMed ID: 6085132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of a unique serum protein in sera obtained from patients with neoplastic diseases and in embryonic and neonatal sera.
    Takahashi A; Yachi A; Anzai T; Wada T
    Clin Chim Acta; 1967 Jul; 17(1):5-12. PubMed ID: 4166654
    [No Abstract]   [Full Text] [Related]  

  • 3. Similarity between leukocyte cultures from cancerous and noncancerous human subjects: an electron microscopic study.
    Chandra S; Moore GE; Brandt PM
    Cancer Res; 1968 Oct; 28(10):1982-9. PubMed ID: 5246715
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum phospholipids in neoplastic disorders.
    Lee LM
    Clin Chim Acta; 1971 Mar; 32(1):25-32. PubMed ID: 4328879
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytochemical study of lactic acid in leukemia cells].
    Piette M; Durand G
    Nouv Rev Fr Hematol; 1969; 9(5):688-96. PubMed ID: 4313092
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum vitamin B 12 and vitamin B 12 binding capacity in chronic myelogenous leukemia and other disorders.
    Rosner F; Schreiber ZA
    Am J Med Sci; 1972 Jun; 263(6):473-80. PubMed ID: 4505888
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of host lymphocytes cultured with cancer cells treated with neuraminidase.
    Watkins E; Ogata Y; Anderson LL; Watkins E; Waters MF
    Nat New Biol; 1971 May; 231(20):83-5. PubMed ID: 4325655
    [No Abstract]   [Full Text] [Related]  

  • 8. [Examination of the density of electric charge of the blood cells in leukemia].
    Rakitianskaia AA
    Probl Gematol Pereliv Krovi; 1966 May; 11(5):24-9. PubMed ID: 4171432
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrocyte sensitivity to in-vitro lysis in leukaemia.
    Catovsky D; Lewis SM; Sherman D
    Br J Haematol; 1971 Nov; 21(5):541-50. PubMed ID: 5286440
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum ferritin levels in hematologic malignant neoplasms.
    Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR
    Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of "virus-like" particles in the plasmas of 255 patients with leukemia and related diseases.
    Newell GR; Harris WW; Bowman KO; Boone CW; Anderson NG
    N Engl J Med; 1968 May; 278(22):1185-91. PubMed ID: 4172474
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-2-microglobulin review: its relevance in clinical oncology.
    Cooper EH; Plesner T
    Med Pediatr Oncol; 1980; 8(4):323-34. PubMed ID: 6161299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-molecular-weight hydroxyproline-protein in relation to immunoglobulins M (IgM) in human blood serum.
    Tomaszewski J; Kowalewski J
    Clin Chim Acta; 1975 Apr; 60(2):185-9. PubMed ID: 47792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the presence of the anti-gamma 2-globulin factor in the serum of patients with leukemia].
    Szmigiel Z; Pawlik L
    Patol Pol; 1971; 22(1):97-103. PubMed ID: 4101894
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiserum against leukemia cell ferritin as a diagnostic tool for malignant neoplasms.
    Mori W; Asakawa H; Taguchi T
    J Natl Cancer Inst; 1975 Sep; 55(3):513-8. PubMed ID: 1057655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the occurrence of additionally limitable gamma globulin fractions in agar gel electrophoresis in patients with neoplastic diseases].
    Lohmann D; Zimmermann S; Gläser A
    Dtsch Med Wochenschr; 1969 Jan; 94(5):213-7. PubMed ID: 4178490
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolism of blood leukocytes in patients with malignant hemopathies and hematosarcomas during the course of chemotherapy].
    Lille I; Gabay P; Clavel B; Saracino RT; Bourdin JS
    Nouv Rev Fr Hematol; 1969; 9(5):715-21. PubMed ID: 4244273
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response.
    Benezra D; Hochman A
    Isr J Med Sci; 1971 Apr; 7(4):553-60. PubMed ID: 5281061
    [No Abstract]   [Full Text] [Related]  

  • 19. Acridine orange metachromasia for characterization of leukocytes in leukemia, lymphoma, and other neoplasms.
    Melamed MR; Adams LR; Traganos F; Zimring A; Kamentsky LA
    Cancer; 1972 May; 29(5):1361-8. PubMed ID: 4112171
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum haptoglobin types and leukemia.
    Nevo S; Tatarsky I
    Hum Genet; 1986 Jul; 73(3):240-4. PubMed ID: 3460960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.